StockData
Immuneering Corp logo

Immuneering Corp (IMRX) stock

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.50+0.04 (+1.16%)

Close on Nov 18, 2026Market cap $226.67MP/E –Yield –

Immuneering price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Immuneering's price to sales ratio was 407.1× on Feb 28, 2023, against 48.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 2023407.1×+154.9
2022Dec 30, 2022252.2×+199.7
2021Dec 31, 202152.4×–

More Immuneering figures

See a number that looks wrong?